Related Experiment Video
Updated: Jun 7, 2025

05:34
5/6 Nephrectomy Using Sharp Bipolectomy Via Midline Laparotomy in Rats
Published on: April 4, 2025
497
[The European Rare Kidney Disease Reference Network]
Tanja Wlodkowski1, Stefanie Haeberle2, Franz Schaefer2
1Zentrum für Kinder und Jugendmedizin, Sektion Pädiatrische Nephrologie, Universitätsklinikum Heidelberg, Im Neuenheimer Feld 430, 69120, Heidelberg, Deutschland. tanja.wlodkowski@med.uni-heidelberg.de.
Innere Medizin (Heidelberg, Germany)
|November 13, 2024
Summary
The European Rare Kidney Disease Reference Network (ERKNet) unites 95 centers to enhance care for 2 million Europeans with rare kidney diseases. It offers online consultations, guidelines, training, and a registry to standardize and improve treatment across Europe.
Area of Science:
- Nephrology
- Rare Diseases
- Genetics
- Public Health
Context:
- Rare kidney diseases affect 2 million Europeans, presenting diverse congenital, inherited, and acquired conditions.
- Existing care for rare kidney diseases is often fragmented, necessitating a coordinated European approach.
- The European Rare Kidney Disease Reference Network (ERKNet) was established to address these challenges.
Purpose:
- To improve the clinical management and standardization of care for patients with rare kidney diseases across Europe.
- To foster collaboration among highly specialized nephrology units and patient advocacy groups.
- To advance research and education in the field of rare kidney diseases.
Summary:
- ERKNet comprises 95 specialized adult and pediatric nephrology units across 72 sites in 24 EU member states, alongside patient advocates (ePAG).
- Key activities include an online consultation service for complex cases, development of clinical practice guidelines, and a postgraduate training program for physicians.
- The European Registry for Rare Kidney Diseases (ERKReg) supports clinical research by collecting demographic and progression data, facilitating cohort identification, and enabling benchmarking for care harmonization.
Impact:
- Enhanced diagnosis and treatment of rare kidney diseases through expert collaboration and standardized guidelines.
- Improved patient outcomes and quality of life for individuals affected by rare kidney diseases.
- Facilitation of clinical research and therapeutic studies through a comprehensive European registry.
- Harmonization and standardization of rare kidney disease care across European reference centers.
Keywords:
Patient informationPostgraduate curriculumPractice recommendationsRare diseasesVirtual consultation
